1st Quarter - Report — IOVINO GROUP LLC for AETNA INC. (2012)

Firm

IOVINO GROUP LLC

Client

AETNA INC.

Income

$60,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 605, HR 2529, S 312, S 1368 - repeal restriction on use of HSAs/FSAs for OTC medications

Lobbyist	Covered position, as disclosed
CHARLYN IOVINO	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2529 (112th), H.R. 605 (112th)

Taxation/Internal Revenue Code TAX

HR 605, S 312 - repeal restriction on use of HSAs/FSAs for OTC medications; HR 2010, S 1089 - expand use of HSAs

Lobbyist	Covered position, as disclosed
CHARLYN IOVINO	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2010 (112th), H.R. 605 (112th)

Insurance INS

HR 605, S 312 - repeal restriction on use of HSAs/FSAs for OTC medications; HR 2010, S 1089 - expand use of HSAs

Lobbyist	Covered position, as disclosed
CHARLYN IOVINO	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 605 (112th), H.R. 2010 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.